New imaging technique could let doctors see lung Cancer's inner workings in real time
NCT ID NCT02676050
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study tested whether two optical imaging agents could be used during a bronchoscopy to visualize activated neutrophils and a cancer-related protein called c-MET in lung tumors. Five participants with lung cancer received the agents through a special catheter while doctors used a miniaturized imaging fiber to detect signals. The goal was to explore whether this technique could provide real-time molecular insights into lung cancer, but the study was terminated early and was not designed to treat the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Optical imaging agents (EMI-137 and NAP)
What this could lead to
If successful, this approach could help doctors see specific cancer-related molecules in real time during a lung exam, potentially improving diagnosis or treatment guidance.
What could go wrong
This was a very small, early exploratory study that was terminated early. It was designed only to test imaging feasibility, not to treat or cure lung cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Infirmary of Edinburgh
Edinburgh, EH16 4TJ, United Kingdom